The Food and Drug Administration (FDA) has cleared Toshiba’s HDR-08A imaging system for Kalare.
The HDR-08A imaging system offers a more intuitive user interface and advanced image processing, increasing the dynamic range of fluoroscopy. With these new system features, clinicians can obtain more information from the images, resulting in quicker, more accurate patient diagnoses.
“The HDR-08A imaging system for Kalare exemplifies how Toshiba continues to improve and develop technology to meet the needs of facilities looking to increase patient throughput,” said Stephen Bumb, director, X-ray Vascular Business Unit, Toshiba. “With an improved user interface and increased dynamic range, more exams can be performed with increased diagnostic confidence.”
